Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synthetic ACTH in Membranous Nephropathy
NCT00694863Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2008
- Primary completion
- Dec 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetracosactide hexaacetate in idiopathic membranous nephropathy (IMN), sponsored by Radboud University Medical Center. Started Jul 2008; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT00694863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694863.